Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors

for
Breast Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18 - 50

Code: NCT07501637

Recruiting

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Non-Small Cell Lung Cancer,
Location: Huntersville NC, Grand Rapids MI, Irving TX
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07807956

Phase 1, Recruiting

Quantitative MRI Assessment of Breast Cancer Therapy Response

for
Breast Cancer
Location: Royal Oak MI, Iowa City IA, Seattle WA
Sponsor: Corewell Health East

Sex: All

Age: 18+

Code: NCT05704062

Recruiting

Improving Genetic Counseling for BRCA+ Mothers

for
Breast Cancer
Location: Washington DC
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT04258280

Recruiting

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

for
Chronic Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07733141

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors

for
Rare CNS Tumor, FOXR2-activated, BCOR ITD Sarcoma, CNS Sarcoma,
Location: Washington D.C. DC
Sponsor: Adriana Fonseca

Sex: All

Age: 0 - 45

Code: NCT07851636

Recruiting

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

for
Ovarian Cancer, Advanced Malignant Solid Tumor
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07389239

Phase 1, Phase 2, Recruiting

Clinical Evaluation of a Multi-functional Beauty Device on Cosmetic Skin Outcomes

for
Skin Appearance, Skin Texture, Skin Sagging, Wrinkles
Location: Baltimore MD
Sponsor: APR Co., Ltd.

Sex: All

Age: 30 - 65

Code: NCT07871708

Recruiting

Driving Time and Facial Skin Hydration Asymmetry in Florida Drivers

for
Skin Diseases, Photoaging, Skin Hydration
Location: Orlando FL
Sponsor: IAS Skin Care

Sex: Female

Age: 25 - 65

Code: NCT07764809

Recruiting

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

for
Advanced Cancer, Pain
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 21+

Code: NCT06117709

Recruiting

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Westerly RI, Waterford CT, Guilford CT, North Haven CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07578116

Phase 3, Recruiting

Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07673614

Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

for
Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06179160

Phase 1, Recruiting

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

for
Metastatic Breast Cancer, HER2-negative Breast Cancer,
Location: Indianapolis IN, Omaha NE, Longmont CO, Vancouver,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 0+

Code: NCT06590857

Phase 1, Phase 2, Recruiting

Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures

for
Diabetes, Cancer, Multiple Sclerosis, Arthritis,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT02777060

Recruiting

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

for
Hormone Receptor Positive, HER2-low or HER2-ultralow,
Location: New York NY
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07701941

Phase 1, Phase 2, Recruiting

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

for
Colorectal Neoplasms, Colorectal Cancer, Breast Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT02732860

Recruiting

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

for
Malignant Solid Tumors
Location: New York NY, Montvale NJ
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 21 - 70+

Code: NCT02421380

Recruiting

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

for
Breast Cancer, Corpus Uteri Cancer, Ovary Cancer,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT07671937

Recruiting

IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors

for
Relapsed Solid Tumor Malignancies,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07672483

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial